← All stocks

Kymera Therapeutics, Inc.

KYMR Net selling
CIK 0001815442 #936 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$744.30K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$744.30K
3 of 3 sales
Net
−$744.30K
−$744.30K against sales at will

By person

14 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Adams Brian
Chief Legal Officer
$744.30K (3)
−$744.30K
50,254
0.0604%
$5.91M
BAKER BROS. ADVISORS LP entity
Director
7,955,916
9.57%
$935.38M
+50.3%
Mainolfi Nello
Chief Executive Officer
666,568
0.8016%
$78.37M
+2.4%
Booth Bruce
Director
466,077
0.5605%
$54.80M
−81.5%
BVF PARTNERS L P/IL entity
Director
318,910
0.3835%
$37.49M
−80.5%
Jacobs Bruce N.
Chief Financial Officer
244,883
0.2945%
$28.79M
+44.2%
Gollob Jared
Chief Medical Officer
117,134
0.1409%
$13.77M
+22.3%
Chiniara Ellen
Chief Legal Officer
80,085
0.0963%
$9.42M
+38.2%
Goodman Noah
Chief Business Officer
47,179
0.0567%
$5.55M
+10,282%
Chadwick Jeremy G
Chief Operating Officer
44,018
0.0529%
$5.18M
−4.6%
Rooney Terence
Chief Medical Officer
38,000
0.0457%
$4.47M
Esposito Pamela
Director
1,000
0.0012%
$117.57K
Albers Jeffrey W.
Director
0
0.0000%
$0.00
Ridloff Elena
Director
0
0.0000%
$0.00
Insider
Date
Role
Action
Shares
Price
Amount
Adams Brian
4 Sep 2026
Chief Legal Officer
Sell
2,137
$117.57
$251.25K
Adams Brian
4 Sep 2026
Chief Legal Officer
Sell
3,025
$116.81
$353.35K
Adams Brian
4 Sep 2026
Chief Legal Officer
Sell
1,209
$115.55
$139.70K

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 0
History held since 21 Aug 2020